bilaterals.org logo
bilaterals.org logo

intellectual property


Japan resurfaces global IPR enforcement framework; EU refers to FTAs
The EU is planning a more detailed intellectual property chapter in its FTAs. In form, not in content, it would be closer to the “US-type” with “detailed things” listed.
Thai Human Rights Commission criticises FTA with US
In what is believed to be the first ever human rights impact assessment of a US FTA conducted at national level, the National Human Rights Commission of Thailand in a draft report concludes that the FTA that Thailand has been negotiating with the United States will violate the human rights of Thai people and affect the country’s sovereignty.
US and India sign historic MoU on bilateral cooperation on IP
The Department of Commerce’s United States Patent and Trademark Office (USPTO) announced on Thursday that Under-Secretary of Commerce for Intellectual Property Jon Dudas and Ajay Dua, secretary of the Indian Ministry of Commerce and Industry (IMCI), recently signed a historic Memorandum of Understanding (MoU) on Bilateral Cooperation between the United States and India on intellectual property issues.
Harmonisation of TRIPS-plus IPR policies and potential impacts on technological capability: A case study of the pharmaceutical industry in Thailand
This study examines the impacts of TRIPS-plus rules on pharmaceutical patents as enshrined in US FTAs by looking at the case of Thailand.
US advises developing country FTA partners not to follow WHO IP plan
Developing countries that have free trade agreements (FTAs) with the United States received an email in the form of a “démarche” from the US government before the 4-8 December 2006 meeting of the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property Rights saying that it had become apparent that the WHO was trying to go beyond its competency and address issues which could have impact on the scope and effect of FTAs.
EU ’strongly committed’ to Mediterranean agriculture
The EU has sought to ease frustrations that agricultural trade within the Mediterranean region has not advanced as quickly as hoped.
The new ’Global Europe’ strategy of the EU: Serving corporations worldwide and at home
Alert to European civil society groups, trade unions and social movements from the Seattle to Brussels Network
US-Russia bilateral/WTO deal pushes new standards for IP protection
In its bilateral negotiation with the United States in order to join the World Trade Organization, Russia appears to have agreed to intellectual property rights standards that push those of the WTO and US law to new levels.
Dominican trade agreement with US contemplates extending patents by 3 years
Legislation proposed for implementing the Free Trade Agreement with Central America and the United States (DR-CAFTA), presented to the Congress by the central government, contemplates a three-year extension beyond the 20 currently in force, for invention patents protection established in the Industrial Property law 20-00.
IP developments in the DR-CAFTA countries
Current state of play with intellectual property law reforms in Central America under the US-DR-CAFTA.
Korea demands recognition for generic drugs
A Korea-US Free Trade Agreement (FTA) for pharmaceuticals is likely to speed up in the fourth round of the FTA talks, which will begin place Monday on Cheju Island.
Data exclusivity regulations in India
New Indian data exclusivity patenting regulations will severely hinder generic AIDS drugs manufacturing in India, and thus less people will have access to AIDS therapy globally. The world’s poor overwhelmingly make up this population with lack of access. Because of this, moral human rights and distributive justice approaches should compel India to take an equity-oriented approach in access to AIDS medicines and reject data exclusivity regulations currently under discussion.
US FTA may cost drug industry $1.2 billion: gov’t
A proposed free trade agreement with the United States is expected to cost as much as 1 trillion won (US$1.2 billion) in damage to the South Korean pharmaceutical industry if the US proposal for the deal is accepted, the South Korean government said.
Aids activists bring patent-drug fight to US
The Thai Network of People Living with HIV/Aids will launch the country’s first campaign abroad against the Thai-US free-trade agreement (FTA) from tomorrow to October 29 in US cities, including San Francisco, New York, Washington and Chicago.
Playing our own game
Sripai Noonsee was in despair after her latest attempt to find a job at an electronics factory at Bang Kadee Industrial Estate ended in failure like so many others. She has been jobless for many months.
Dominican pharma reiterates US demands exceed DR-CAFTA stipulations
The Dominican Association of Pharmaceutical Industries denounced yesterday as “abusive demands” the requirements recently posed by the United States Trade Representative, prior to implementing the Free Trade Agreement (DR-CAFTA).
Pro-FTA advisers a worry for HIV groups
HIV/Aids groups claim that if Thailand signs a free-trade agreement (FTA) with the United States, the access to life-saving treatment for HIV positive people could be considerably compromised.
IP rights under investment agreements: the TRIPS-plus implications for enforcement and protection of public interest
One of the issues that has recently started to influence the negotiations for new investment agreements involves the question of the status of IP rights and the impact of investment agreements on the rights, obligations and regulatory discretions of countries under the Agreement on Trade-Related Aspect of Intellectual Property Rights (TRIPS) of the World Trade Organization (WTO).